GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » EV-to-EBIT

Tivic Health Systems (Tivic Health Systems) EV-to-EBIT : 0.18 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tivic Health Systems's Enterprise Value is $-1.49 Mil. Tivic Health Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.25 Mil. Therefore, Tivic Health Systems's EV-to-EBIT for today is 0.18.

The historical rank and industry rank for Tivic Health Systems's EV-to-EBIT or its related term are showing as below:

TIVC' s EV-to-EBIT Range Over the Past 10 Years
Min: -13.03   Med: -0.07   Max: 0.41
Current: 0.18

During the past 5 years, the highest EV-to-EBIT of Tivic Health Systems was 0.41. The lowest was -13.03. And the median was -0.07.

TIVC's EV-to-EBIT is ranked better than
97.17% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.215 vs TIVC: 0.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tivic Health Systems's Enterprise Value for the quarter that ended in Dec. 2023 was $-0.39 Mil. Tivic Health Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.25 Mil. Tivic Health Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2,130.28%.


Tivic Health Systems EV-to-EBIT Historical Data

The historical data trend for Tivic Health Systems's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems EV-to-EBIT Chart

Tivic Health Systems Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -3.81 -0.32 0.05

Tivic Health Systems Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 0.02 -0.10 0.27 0.05

Competitive Comparison of Tivic Health Systems's EV-to-EBIT

For the Medical Devices subindustry, Tivic Health Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tivic Health Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's EV-to-EBIT falls into.



Tivic Health Systems EV-to-EBIT Calculation

Tivic Health Systems's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-1.485/-8.245
=0.18

Tivic Health Systems's current Enterprise Value is $-1.49 Mil.
Tivic Health Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tivic Health Systems  (NAS:TIVC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tivic Health Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-8.245/-0.387038
=2,130.28 %

Tivic Health Systems's Enterprise Value for the quarter that ended in Dec. 2023 was $-0.39 Mil.
Tivic Health Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tivic Health Systems EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tivic Health Systems (Tivic Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Executives
Sheryle Bolton director 55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria director C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst director, officer: Chief Executive Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein officer: Chief Scientific Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia officer: Chief Operating Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach officer: Interim CFO 25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai officer: Chief Financial Officer C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude 10 percent owner 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz officer: Chief Financial Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025